Becker's ASC

New AGA guidance for ulcerative colitis treatment: 8 things to know

The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...
PharmiWeb

Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Co…

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...
Healio

‘It is very clear’: Blocking TL1A an important factor in treatment of ulcerative colitis

Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients in the PRA023 group achieved clinical remission at 12 weeks vs. placebo (26.5% ...
Healio

Clinicians ‘increasingly comfortable’ using mirikizumab earlier in ulcerative colitis

More than a quarter of patients with ulcerative colitis do not receive prior advanced therapy before initiating mirikizumab, ...
WebMD

Managing Ulcerative Colitis With Tremfya

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
Hosted on MSN

Colitis vs. Ulcerative Colitis: What’s the Difference?

Colitis Symptoms Ulcerative Colitis Symptoms How They Differ Treatment Options Colitis and ulcerative colitis (UC) can look very similar because they share symptoms like abdominal pain, diarrhea, and ...
The American Journal of Managed Care

Clarifying the Role of EEN Diet as Ulcerative Colitis Therapy

EEN is primarily used for Crohn's disease, but its effectiveness in ulcerative colitis is unclear, necessitating further research. A systematic review analyzed 70 studies, finding no significant ...